# Report: 10_AC_gliosis_like_2 (run_2.md)

**Cell type:** glioblastoma cells
**Disease:** glioblastoma (GBM)
**Tissue:** brain

## Program Summaries
### Epithelial-Mesenchymal Transition
Coordinated upregulation of mesenchymal transcription factors and downregulation of epithelial adhesion molecules, driving acquisition of migratory and invasive phenotypes in GBM. This program involves transcriptional reprogramming through WNT pathway activation, canonical EMT transcription factors, and matrix remodeling, representing a reversible plastic state induced by microenvironmental cues such as hypoxia and inflammatory signals.

**Predicted impacts:**
- Shift from epithelial-like to mesenchymal phenotype with enhanced motility
- Increased expression of invasion-promoting proteases and reduced cell-cell adhesion
- Acquisition of stemness markers and therapeutic resistance
- Enhanced propensity for migration into surrounding brain tissue

**Supporting genes:** LEF1, HOPX, HMGA2, VAV3, ITGA3, IQGAP2, RHOJ, ARHGAP26, ARHGAP6, ADAM19, ADAMTS9-AS1, SERPINE1, PLAT, CDH4, SPRY1, SPRY2, SPRY4, WNT16

**References:** [14], [17], [9]

**Biological processes:**
- Transcriptional reprogramming via WNT/beta-catenin signaling: LEF1, WNT16
- Focal adhesion and cytoskeletal remodeling: ITGA3, IQGAP2, RHOJ, ARHGAP26, ARHGAP6, WIPF3
- Matrix metalloproteinase activation and ECM degradation: ADAM19, ADAMTS9-AS1, SERPINE1, PLAT

**Cellular components:**
- Cell-cell adhesion molecules: CDH4

**Reference notes:**
- Glioma cells undergoing EMT acquire potential to initiate metastasis and invasion, highly affected by tumor microenvironment
- EMT is reversible biological process in epithelial cells, epigenetic mechanisms more crucial than genetic changes
- Transcriptome changes in glioma NS formation show upregulation of EMT genes, invasion and migration markers

### Calcium-Mediated Proliferation and Survival
Coordinated activation of calcium/calmodulin-dependent signaling pathways that promote GBM cell proliferation, invasion, and therapeutic resistance. Involves calcium-permeable glutamate receptor activation, calcium/calmodulin-dependent protein kinases, and downstream effector pathways including MAPK/ERK and PI3K/AKT signaling. This program couples cellular excitability to oncogenic signaling.

**Predicted impacts:**
- Enhanced intracellular calcium dynamics and sustained calcium signaling
- Activation of MAPK/ERK and AKT/mTOR proliferative pathways
- Increased cell proliferation and reduced apoptosis
- Enhanced invasive and migratory capacity of tumor cells
- Coupling of neuronal signaling to glioma survival and growth

**Supporting genes:** CAMK2B, CAMK2A, GRM7, GABBR2, TRPM8, TRPM3, CA2, CA10, SLC4A4, SLC24A2, SLC18A1, RCAN1, GLRA2

**References:** [38], [49]

**Biological processes:**
- Calcium influx through ionotropic glutamate receptors: GRM7, GLRA2
- Calcium/calmodulin-dependent protein kinase signaling: CAMK2B, CAMK2A, RCAN1
- GABA receptor signaling and neuronal-tumor crosstalk: GABBR2
- Ion transport and cellular excitability: TRPM8, TRPM3, CA2, CA10, SLC4A4, SLC24A2, SLC18A1

**Cellular components:**
- Ion channels and transporters: TRPM8, TRPM3, CA2, CA10, SLC4A4, SLC24A2, SLC18A1
- Calcium-binding and buffering proteins: RCAN1

**Reference notes:**
- Dynamic and complex interplay between synaptic communication and brain cancer progression is critical frontier in understanding tumor growth in brain's microenvironment
- Glutamatergic and calcium signaling may provide positive feedback to promote glioma formation

### Glioma Stem Cell Maintenance
Transcriptional and post-transcriptional regulation of self-renewal capacity, stemness marker expression, and resistance to differentiation in glioblastoma stem cells. This program involves transcription factors that maintain pluripotency-like states, Wnt/Notch signaling, and epigenetic regulation. Glioma stem cells are characterized by high tumorigenicity, self-renewal, invasiveness, and therapy resistance.

**Predicted impacts:**
- Sustained self-renewal and clonogenic capacity of GBM stem cells
- Resistance to differentiation and maintenance of pluripotency-like state
- Enhanced tumorigenicity and intracranial tumor formation
- Increased invasiveness and metastatic potential
- Elevated resistance to chemo- and radiotherapy

**Supporting genes:** HMGA2, EGR1, EGR3, LEF1, HOPX, WNT16, JAG1, SOX1-OT, PDGFD, CAMK2B, CAMK2A

**References:** [20], [45]

**Biological processes:**
- Stemness transcription factor regulation: EGR1, EGR3, HMGA2, HOPX
- Wnt/Notch pathway signaling in stem cell maintenance: LEF1, WNT16, JAG1
- Growth factor signaling loops: EGR1, PDGFD, SOX1-OT
- Cell cycle progression and proliferation: EGR1, EGR3, HMGA2, CAMK2B

**Cellular components:**
- Transcriptional co-activators: HMGA2, EGR1, HOPX

**Reference notes:**
- HMGA2 promotes stemness, invasion, and tumorigenicity in GBM. Targeting HMGA2 may be therapeutically beneficial
- EGR1 expression frequent in GBM and restricted to proliferating/progenitor cells. EGR1 essential for GSC proliferation

### Integrin-Mediated Cell Invasion
Coordinated signaling through integrin receptors and their interaction with extracellular matrix components to promote GBM cell migration, invasion, and adhesion dynamics. Involves integrin clustering, focal adhesion kinase signaling, and activation of downstream kinase cascades that control cytoskeletal organization and enable penetration through tissue barriers.

**Predicted impacts:**
- Enhanced migration and invasion through ECM
- Increased focal adhesion dynamics enabling rapid cell motility
- Sustained ERK1/2 signaling promoting invasive phenotype
- Penetration of blood-brain barrier and peritumoral invasion
- Dynamic regulation of cell adhesion-deadhesion cycles

**Supporting genes:** ITGA3, SNED1, IQGAP2, RHOJ, ARHGAP26, ARHGAP6, WIPF3, SPRY1, SPRY2, SPRY4, CAMK2B

**References:** [31], [8]

**Biological processes:**
- Integrin-ECM binding and focal adhesion assembly: ITGA3, SNED1, IQGAP2
- ERK1/2 pathway activation downstream of integrin signaling: ITGA3, CAMK2B, SPRY1, SPRY2, SPRY4
- Cytoskeletal reorganization and cell polarity: ITGA3, IQGAP2, RHOJ, ARHGAP26, ARHGAP6, WIPF3

**Cellular components:**
- Integrin receptors and associated proteins: ITGA3, SNED1
- Focal adhesion kinase and adaptor proteins: IQGAP2, WIPF3

**Reference notes:**
- Integrin α3 is prime candidate for anti-invasion therapy for GBM
- SNED1 is required for neural crest cell migration and necessary for metastatic dissemination of tumor cells

### Extracellular Matrix Remodeling
Coordinated expression and modification of extracellular matrix proteins including collagens, proteoglycans, and matricellular proteins, coupled with protease activity to reshape the tumor microenvironment. This program supports cell adhesion turnover, angiogenesis, immune infiltration, and establishment of a permissive environment for tumor progression and invasion.

**Predicted impacts:**
- Enhanced deposition of collagen scaffold around tumor cells
- Increased proteolytic activity remodeling ECM architecture
- Modified heparan sulfate composition affecting growth factor bioavailability
- Creation of permissive microenvironment for tumor cell migration and invasion
- Altered immune cell infiltration through ECM remodeling

**Supporting genes:** COL22A1, COL23A1, COL25A1, COL27A1, COL19A1, POSTN, SNED1, ADAM19, ADAMTS9-AS1, HS3ST5, SERPINE1

**References:** [12], [26]

**Biological processes:**
- Collagen deposition and cross-linking: COL22A1, COL23A1, COL25A1, COL27A1, COL19A1
- Matricellular protein expression: POSTN
- Protease secretion and ECM degradation: ADAM19, ADAMTS9-AS1
- Heparan sulfate proteoglycan modification: HS3ST5

**Cellular components:**
- Collagen molecules: COL22A1, COL23A1, COL25A1, COL27A1, COL19A1
- Matricellular proteins: POSTN, SNED1
- Glycosaminoglycan biosynthesis: HS3ST5

**Reference notes:**
- Collagen genes could serve as potential therapeutic targets for glioma management
- Matrisome-high GBM associated with worse prognosis and identified prognostic matrix code defines functional GBM subtypes

### Receptor Tyrosine Kinase Signaling
Coordinated regulation of growth factor signaling through EGFR, PDGFR, ALK, and related receptor tyrosine kinases coupled with feedback inhibition mechanisms. This program drives proliferation, survival, and invasion through MAPK/ERK and PI3K/AKT pathways, with importance for maintaining tumor growth and establishing therapeutic resistance.

**Predicted impacts:**
- Enhanced growth factor-driven proliferation via MAPK/ERK activation
- Sustained survival signaling through PI3K/AKT pathways
- Increased invasive and migratory capacity
- Resistance to differentiation and maintenance of stemness
- Therapeutic resistance through redundant signaling pathways

**Supporting genes:** FHL2, EGR1, ALK, SPRY1, SPRY2, SPRY4, CAMK2B, CAMK2A, PDGFD, TFCP2L1, PCSK5

**References:** [21], [7]

**Biological processes:**
- EGFR-FHL2 signaling axis: FHL2, TFCP2L1
- PDGF signaling in stem cell maintenance: EGR1, PDGFD
- ALK fusion signaling: ALK
- MAPK/ERK pathway activation and feedback inhibition: SPRY1, SPRY2, SPRY4, CAMK2B, CAMK2A
- Proprotein convertase inhibition: PCSK5

**Cellular components:**
- Receptor tyrosine kinases: ALK, FHL2
- MAPK kinase cascades: SPRY1, SPRY2, SPRY4, CAMK2B

**Reference notes:**
- Targeting FHL2 represents novel strategy for EGFR-positive GBM therapy
- ALK inhibitors show responsiveness in ALK-fused GBM cellular and mouse models including patient-derived cells

### Immune Microenvironment Modulation
Expression of immunomodulatory genes that suppress anti-tumor immune responses and promote immune cell recruitment to create an immunosuppressive tumor microenvironment. Includes genes encoding cytokines, cytokine receptors, immune checkpoint molecules, and factors affecting immune cell differentiation and function.

**Predicted impacts:**
- Recruitment and polarization of immunosuppressive myeloid cells
- Reduced anti-tumor T cell and NK cell function
- Enhanced tumor escape from immune surveillance
- Increased expression of immune checkpoint ligands
- Establishment of immunosuppressive tumor microenvironment supporting tumor progression

**Supporting genes:** GDF15, METTL7B, IL27RA, IL1RAP, IRAK2

**References:** [13], [47]

**Biological processes:**
- Inflammatory cytokine signaling: GDF15
- IL-1 and IL-27 receptor signaling: IL27RA, IL1RAP, IRAK2
- Immune checkpoint regulation and METTL7B-mediated immunosuppression: METTL7B
- M2 macrophage polarization and recruitment: GDF15, METTL7B

**Cellular components:**
- Cytokine and chemokine molecules: GDF15, PDGFD
- Cytokine receptors: IL27RA, IL1RAP

**Reference notes:**
- GDF15 could serve as interesting prognostic biomarker for glioma
- METTL7B presents clinical prognostic value and METTL7B-related prognostic signature predicts overall survival of glioma patients

### Cuproptosis and Metabolic Reprogramming
Regulation of copper-dependent cell death pathways (cuproptosis) and metabolic shifts supporting tumor aggressiveness. Involves genes regulating copper homeostasis, lipoylation of metabolic enzymes, and mitochondrial function. Recent evidence suggests cuproptosis as alternative tumor suppression mechanism distinct from apoptosis and ferroptosis.

**Predicted impacts:**
- Enhanced sensitivity to copper-induced cell death pathways
- Altered mitochondrial metabolism and oxidative stress
- Potential therapeutic vulnerability through cuproptosis induction
- Metabolic reprogramming supporting tumor growth

**Supporting genes:** COL22A1

**References:** [3]

**Biological processes:**
- Cuproptosis-related gene expression: COL22A1
- Metabolic enzyme lipoylation: COL22A1

**Reference notes:**
- COL22A1 revealed as cuproptosis-related combined regimen target for GBM with potential therapeutic benefit

### Tetraspanin-Mediated Cell Adhesion
Coordinated regulation of tetraspanin proteins that mediate cell-cell adhesion, cell-ECM interactions, and formation of specialized membrane microdomains. Tetraspanins function as adaptor proteins connecting surface receptors to cytoskeletal and signaling machinery, with roles in tumor heterogeneity and immune microenvironment formation.

**Predicted impacts:**
- Enhanced cell-ECM adhesion through integrin-tetraspanin complexes
- Facilitation of EMT through tetraspanin-mediated signaling
- Regulation of immune cell infiltration patterns
- Promotion of cell migration and invasion
- Modulation of tumor microenvironment composition

**Supporting genes:** TSPAN18

**References:** [43]

**Biological processes:**
- Tetraspanin-integrin complex formation: TSPAN18
- EMT pathway modulation: TSPAN18
- Immune infiltration and tumor microenvironment formation: TSPAN18

**Cellular components:**
- Tetraspanin proteins: TSPAN18

**Reference notes:**
- Tetraspanins comprehensively elaborate prognostic value and potential role in GBM pathological mechanisms and tumor microenvironment remodeling

### Transcriptional Regulation of Differentiation
Control of neural differentiation states and lineage specification through transcription factors that balance stem cell maintenance with differentiation. Involves genes regulating neural progenitor fate decisions, astrocytic differentiation, and oligodendrocytic commitment, which determine tumor cell plasticity and phenotypic heterogeneity in GBM.

**Predicted impacts:**
- Balanced control of stem cell maintenance versus differentiation
- Phenotypic heterogeneity within tumor cell population
- Plasticity enabling adaptation to environmental stresses
- Modulation of mesenchymal versus proneural differentiation states
- Potential for therapeutic targeting of differentiation pathways

**Supporting genes:** HOPX, SOX1-OT

**References:** [32]

**Biological processes:**
- Lineage specification and differentiation control: HOPX
- Neural progenitor differentiation: SOX1-OT, HOPX
- Developmental pathway regulation: HOPX

**Cellular components:**
- Transcription factors controlling differentiation: HOPX, SOX1-OT

**Reference notes:**
- HOPX has recently been identified as one of regulators of differentiation and proliferation states in GBM

## References
- [12] Notes: Matrisome-high GBM associated with worse prognosis and identified prognostic matrix code defines functional GBM subtypes
- [13] Notes: GDF15 could serve as interesting prognostic biomarker for glioma
- [14] Notes: Glioma cells undergoing EMT acquire potential to initiate metastasis and invasion, highly affected by tumor microenvironment
- [17] Notes: EMT is reversible biological process in epithelial cells, epigenetic mechanisms more crucial than genetic changes
- [20] Notes: EGR1 expression frequent in GBM and restricted to proliferating/progenitor cells. EGR1 essential for GSC proliferation
- [21] Notes: Targeting FHL2 represents novel strategy for EGFR-positive GBM therapy
- [26] Notes: Collagen genes could serve as potential therapeutic targets for glioma management
- [3] Notes: COL22A1 revealed as cuproptosis-related combined regimen target for GBM with potential therapeutic benefit
- [31] Notes: SNED1 is required for neural crest cell migration and necessary for metastatic dissemination of tumor cells
- [32] Notes: HOPX has recently been identified as one of regulators of differentiation and proliferation states in GBM
- [38] Notes: Dynamic and complex interplay between synaptic communication and brain cancer progression is critical frontier in understanding tumor growth in brain's microenvironment
- [43] Notes: Tetraspanins comprehensively elaborate prognostic value and potential role in GBM pathological mechanisms and tumor microenvironment remodeling
- [45] Notes: HMGA2 promotes stemness, invasion, and tumorigenicity in GBM. Targeting HMGA2 may be therapeutically beneficial
- [47] Notes: METTL7B presents clinical prognostic value and METTL7B-related prognostic signature predicts overall survival of glioma patients
- [49] Notes: Glutamatergic and calcium signaling may provide positive feedback to promote glioma formation
- [7] Notes: ALK inhibitors show responsiveness in ALK-fused GBM cellular and mouse models including patient-derived cells
- [8] Notes: Integrin α3 is prime candidate for anti-invasion therapy for GBM
- [9] Notes: Transcriptome changes in glioma NS formation show upregulation of EMT genes, invasion and migration markers
